S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.03 (+0.49%)
MSFT   335.05 (-0.47%)
FB   335.04 (-0.88%)
GOOGL   2,898.93 (-0.40%)
AMZN   3,575.01 (+0.38%)
TSLA   1,161.62 (+2.17%)
NVDA   330.08 (-1.10%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.06 (+0.00%)
AMD   162.54 (+0.39%)
GE   97.13 (-1.29%)
MU   86.85 (+0.82%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.03 (+0.49%)
MSFT   335.05 (-0.47%)
FB   335.04 (-0.88%)
GOOGL   2,898.93 (-0.40%)
AMZN   3,575.01 (+0.38%)
TSLA   1,161.62 (+2.17%)
NVDA   330.08 (-1.10%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.06 (+0.00%)
AMD   162.54 (+0.39%)
GE   97.13 (-1.29%)
MU   86.85 (+0.82%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.03 (+0.49%)
MSFT   335.05 (-0.47%)
FB   335.04 (-0.88%)
GOOGL   2,898.93 (-0.40%)
AMZN   3,575.01 (+0.38%)
TSLA   1,161.62 (+2.17%)
NVDA   330.08 (-1.10%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.06 (+0.00%)
AMD   162.54 (+0.39%)
GE   97.13 (-1.29%)
MU   86.85 (+0.82%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
S&P 500   4,629.00 (-0.56%)
DOW   34,830.71 (-0.87%)
QQQ   399.20 (-0.12%)
AAPL   161.03 (+0.49%)
MSFT   335.05 (-0.47%)
FB   335.04 (-0.88%)
GOOGL   2,898.93 (-0.40%)
AMZN   3,575.01 (+0.38%)
TSLA   1,161.62 (+2.17%)
NVDA   330.08 (-1.10%)
BABA   130.12 (-1.13%)
NIO   40.31 (-0.37%)
CGC   11.06 (+0.00%)
AMD   162.54 (+0.39%)
GE   97.13 (-1.29%)
MU   86.85 (+0.82%)
T   23.67 (-0.92%)
F   19.55 (-0.61%)
DIS   146.64 (-0.79%)
ACB   6.38 (-0.93%)
AMC   36.73 (-0.30%)
PFE   52.53 (+0.25%)
BA   196.10 (-1.21%)
NASDAQ:BNGO

Bionano Genomics SEC Filings & 10K Form

$3.91
-0.02 (-0.51%)
(As of 11/30/2021 09:52 AM ET)
Add
Compare
Today's Range
$3.89
▼
$4.00
50-Day Range
$3.93
▼
$6.12
52-Week Range
$0.48
▼
$15.69
Volume
43,662 shs
Average Volume
10.45 million shs
Market Capitalization
$1.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.78

Bionano Genomics (NASDAQ:BNGO) SEC Filings

DateFilerForm TypeView
08/19/2021
4:49 PM		BARKER DAVID L (Reporting)
Bionano Genomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:48 PM		Bionano Genomics (Issuer)
Luderer Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:47 PM		Bionano Genomics (Issuer)
TWOMEY CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:47 PM		Bionano Genomics (Issuer)
Vuori Kristiina MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:20 PM		Bionano Genomics (Issuer)
Mamuszka Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:18 PM		Bionano Genomics (Issuer)
Linney Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
3:02 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2021
8:21 PM		Bionano Genomics (Issuer)
Shippy Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
8:20 PM		Bionano Genomics (Issuer)
Shippy Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2021
6:19 PM		BARKER DAVID L (Reporting)
Bionano Genomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:17 PM		Bionano Genomics (Issuer)
TWOMEY CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:16 PM		Bionano Genomics (Issuer)
Mamuszka Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:13 PM		Bionano Genomics (Issuer)
Luderer Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:12 PM		Bionano Genomics (Issuer)
Linney Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2021
6:10 PM		Bionano Genomics (Issuer)
Vuori Kristiina MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:39 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2021
4:03 PM		Bionano Genomics (Issuer)
Priar Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2021
3:36 PM		Bionano Genomics (Issuer)
Stewart Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
6:16 PM		Bionano Genomics (Issuer)
Holmlin R. Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
6:15 PM		Bionano Genomics (Issuer)
OLDAKOWSKI MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
4:26 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2021
3:31 PM		Bionano Genomics (Filer)
Form DEFA14A
04/23/2021
3:16 PM		Bionano Genomics (Issuer)
Chaubey Alka (Reporting)
Form 3/A
04/02/2021
5:33 PM		Bionano Genomics (Issuer)
Chaubey Alka (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
5:33 PM		Bionano Genomics (Issuer)
Stewart Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
5:32 PM		Bionano Genomics (Issuer)
Holmlin R. Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
5:31 PM		Bionano Genomics (Issuer)
OLDAKOWSKI MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
4:29 PM		Bionano Genomics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/25/2021
3:24 PM		Bionano Genomics (Issuer)
Stewart Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
5:06 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2021
5:03 AM		Bionano Genomics (Filer)
Form 424B5
01/19/2021
3:48 PM		Bionano Genomics (Filer)
Form 424B5
01/19/2021
3:11 PM		Bionano Genomics (Filer)
Form S-3ASR
01/11/2021
7:37 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
6:04 AM		Bionano Genomics (Filer)
Form 424B5
01/08/2021
6:35 AM		Bionano Genomics (Filer)
Form S-3MEF
01/08/2021
5:02 AM		Bionano Genomics (Filer)
Form 8-K/A
01/07/2021
3:41 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2021
3:36 PM		Bionano Genomics (Filer)
Form 424B5
01/04/2021
5:03 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
3:31 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
3:01 PM		Bionano Genomics (Filer)
Form 8-K/A
10/15/2020
4:26 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
3:05 PM		Bionano Genomics (Filer)
Form 8-K/A
09/03/2020
5:41 PM		Bionano Genomics (Issuer)
Chaubey Alka (Reporting)
Form 4/A
09/03/2020
11:53 AM		Bionano Genomics (Issuer)
Stewart Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
11:48 AM		Bionano Genomics (Issuer)
Stewart Christopher P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2020
11:43 AM		Bionano Genomics (Issuer)
Chaubey Alka (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
11:34 AM		Bionano Genomics (Issuer)
Chaubey Alka (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2020
8:05 AM		Bionano Genomics (Filer)
Form DEFA14A
09/02/2020
4:12 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
4:25 PM		Bionano Genomics (Filer)
Form DEFA14A
08/28/2020
3:06 PM		Bionano Genomics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/28/2020
8:21 AM		Bionano Genomics (Filer)
Form DEFA14A
08/27/2020
3:16 PM		Bionano Genomics (Filer)
Form 424B5
08/26/2020
4:12 PM		Bionano Genomics (Filer)
Form DEFA14A
08/26/2020
7:05 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
11:15 PM		Bionano Genomics (Filer)
Form EFFECT
08/24/2020
6:35 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2020
5:28 AM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:04 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2020
8:03 AM		Bionano Genomics (Filer)
Form DEFA14A
08/03/2020
7:57 AM		Bionano Genomics (Filer)
Form DEF 14A
07/24/2020
3:42 PM		Bionano Genomics (Filer)
Form PRE 14A
07/07/2020
11:16 PM		Bionano Genomics (Filer)
Form EFFECT
07/02/2020
7:37 PM		Bionano Genomics (Issuer)
Vuori Kristiina MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:35 PM		Bionano Genomics (Issuer)
TWOMEY CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:32 PM		Bionano Genomics (Issuer)
Luderer Albert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:31 PM		Bionano Genomics (Issuer)
Mamuszka Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:29 PM		Bionano Genomics (Issuer)
Linney Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
7:26 PM		BARKER DAVID L (Reporting)
Bionano Genomics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2020
3:06 PM		Bionano Genomics (Filer)
Form S-3/A
06/22/2020
4:00 PM		Bionano Genomics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/18/2020
8:15 AM		Bionano Genomics (Filer)
Form DEFA14A
06/17/2020
5:02 AM		Bionano Genomics (Filer)
Form DEFR14A
05/14/2020
4:28 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
4:29 PM		Bionano Genomics (Filer)
Form PRER14A
05/06/2020
4:30 PM		Bionano Genomics (Filer)
Form PRE 14A
05/06/2020
1:30 PM		Bionano Genomics (Issuer)
Mamuszka Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
1:29 PM		Bionano Genomics (Issuer)
Linney Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2020
1:26 PM		Bionano Genomics (Issuer)
Mamuszka Hannah (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/06/2020
1:25 PM		Bionano Genomics (Issuer)
Linney Yvonne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2020
3:22 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2020
1:50 PM		Bionano Genomics (Issuer)
TWOMEY CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2020
3:00 PM		Bionano Genomics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2020
5:04 AM		Bionano Genomics (Filer)
Form 424B4
04/01/2020
11:15 PM		Bionano Genomics (Filer)
Form EFFECT
04/01/2020
8:47 PM		Bionano Genomics (Filer)
Form S-1MEF
04/01/2020
8:45 PM		Bionano Genomics (Filer)
Form POS EX
03/24/2020
4:17 PM		Bionano Genomics (Filer)
Form S-1/A
03/19/2020
11:15 PM		Bionano Genomics (Filer)
Form EFFECT
03/19/2020
7:52 PM		Bionano Genomics (Filer)
Form 424B3
03/11/2020
5:07 AM		Bionano Genomics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/10/2020
4:31 PM		Bionano Genomics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2020
1:09 PM		Bionano Genomics (Issuer)
Ward Michael James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2020
1:08 PM		Bionano Genomics (Issuer)
Robinson Warren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2020
1:07 PM		Bionano Genomics (Issuer)
OLDAKOWSKI MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2020
1:06 PM		Bionano Genomics (Issuer)
Holmlin R. Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:25 PM		Bionano Genomics (Issuer)
Robinson Warren (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
6:24 PM		Bionano Genomics (Issuer)
Borodkin Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.